Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
PHASE3CompletedINTERVENTIONAL
Enrollment
226
Participants
Timeline
Start Date
June 30, 1994
Conditions
OsteosarcomaLocalised High Grade Osteosarcoma of the Limbs
Interventions
DRUG
Etoposide, Ifosfamide, Methotrexate
DRUG
Doxorubicin, Methotrexate
Trial Locations (1)
94805
Institut Gustave-Roussy, Villejuif
All Listed Sponsors
lead
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
NCT00180908 - Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | Biotech Hunter | Biotech Hunter